Feedback / Questions
ABD-147 - Abdera Therap
https://www.businesswire.com/news/home/20230419005844/en/Abdera-Therapeutics-Debuts-With-142-Million-in-Financing-to-Engineer-and-Advance-Best-in-Class-Antibody-Based-Radiopharmaceuticals-for-Cancer
Apr 20, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev